Rio Tinto analysis reveals 28% upside potential through operational excellence and energy transition positioning, with fair value $107.22 USD versus current market pricing.
View noteAustralia's only pure-play agricultural REIT trades 12% below $2.16 fair value with 6.1% yield, though refinancing risk at 15.5x leverage creates execution dependency
View noteDeep value opportunity trading at $1.84 vs $6.51 fair value. Chinese brand expansion and margin recovery from cyclical trough. High risk, high reward.
View notePioneer Credit analysis: SELL rating, fair value $0.44 vs current $0.59. Structural negative FCF despite profitability, 6.9x leverage approaching covenants.
View notePro Medicus fair value $16.11 with 80% EBITDA margins facing inevitable compression as competitive response intensifies over 3-5 years.
View noteMarket leader with 26% share trading at $2.47 vs $1.66 fair value. Strong growth trajectory offset by execution risk and unsustainable 75.5% margins.
View noteTrading at $3.65 vs fair value $9.53 (161% upside). Market leader with 16.6% share consolidating fragmented industry. Strong cash generation, proven acquisition track record.
View noteEngineering services provider trading at $20.22 vs $11.62 fair value with EBITDA margins at unsustainable 7.0% peak facing labour cost pressures
View noteMirvac Group analysis reveals 73% downside to fair value of $0.73 despite quality assets, driven by unsustainable 5.7x debt/EBITDA leverage and negative free cash flow through FY32.
View noteSELL rating with $5.34 fair value vs $8.26 current price. Strong operator facing labour cost pressures and scaling challenges.
View noteHansen Technologies trades at $6.04 versus fair value of $4.87, with 28.4% EBITDA margins compressing to 25.3% as competitive moats narrow over 5-7 years.
View noteTrading at $0.41 vs $0.65 fair value. 9%+ dividend yield, 6.8x EV/EBITDA vs 9.5x peers. Technology disruption risks offset by defensive positioning.
View note